Related references
Note: Only part of the references are listed.Recent trends in cancer survival across Europe between 2000 and 2004: A model-based period analysis from 12 cancer registries
A. Gondos et al.
EUROPEAN JOURNAL OF CANCER (2008)
Specialized care and survival of ovarian cancer patients in the Netherlands: Nationwide cohort study
Flora Vernooij et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Quantifying the role of PSA screening in the US prostate cancer mortality decline
Ruth Etzioni et al.
CANCER CAUSES & CONTROL (2008)
Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data
Arduino Verdecchia et al.
LANCET ONCOLOGY (2007)
Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study
Franco Berrino et al.
LANCET ONCOLOGY (2007)
Model based hybrid analysis of cancer patient survival
Hermann Brenner et al.
EUROPEAN JOURNAL OF CANCER (2007)
The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: A systematic review
Flora Vernooij et al.
GYNECOLOGIC ONCOLOGY (2007)
Interpreting trends in cancer patient survival
P. W. Dickman et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Chronic myeloid leukemia:: Diagnosis and treatment
Alfonso Quintas-Cardama et al.
MAYO CLINIC PROCEEDINGS (2006)
Progress and prospects on melanoma: The way forward for early detection and reduced mortality
MA Weinstock
CLINICAL CANCER RESEARCH (2006)
Breast cancer: Achievements in adjuvant systemic therapies in the pre-genomic era
Mariantonietta Colozzaa et al.
ONCOLOGIST (2006)
Up-to-date estimates of cancer patient survival even with common latency in cancer registration
Hermann Brenner et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Lymph node evaluation in colorectal cancer patients: A population-based study
NN Baxter et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Impact of a surgical training programme on rectal cancer outcomes in Stockholm
A Martling et al.
BRITISH JOURNAL OF SURGERY (2005)
Evidence of prostate cancer screening in a UK region
A Gavin et al.
BJU INTERNATIONAL (2004)
Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation computational realisation and applications
H Brenner et al.
EUROPEAN JOURNAL OF CANCER (2004)
Practice of opportunistic prostate-specific antigen screening in Italy: data from the Health Search database
G D'Ambrosio et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2004)
Standard cancer patient population for age standardising survival ratios
I Corazziari et al.
EUROPEAN JOURNAL OF CANCER (2004)
Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases
H Brenner et al.
EUROPEAN JOURNAL OF CANCER (2004)
Up-to-date long-term survival of cancer patients:: an evaluation of period analysis on Swedish Cancer Registry data
M Talbäck et al.
EUROPEAN JOURNAL OF CANCER (2004)
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century
M. P. Coleman et al.
ANNALS OF ONCOLOGY (2003)
Lead times and overdetection due to prostate-specific antigen screening:: Estimates from the European randomized study of screening for prostate cancer
G Draisma et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab
J Boye et al.
ANNALS OF ONCOLOGY (2003)
Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer
RE Peschel et al.
LANCET ONCOLOGY (2003)
Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm Trial
JB Trimbos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary
M. Sant et al.
ANNALS OF ONCOLOGY (2003)
Training and quality assurance for rectal cancer: 20 years of data is enough
P Quirke
LANCET ONCOLOGY (2003)
Comments on the St. Gallen consensus 2003 on the primary therapy of early breast cancer
HJ Senn et al.
BREAST (2003)
Incidence of and survival from malignant melanoma in Scotland: an epidemiological study
RM MacKie et al.
LANCET (2002)
A national strategic change in treatment policy for rectal cancer implementation of total mesorectal excision as routine treatment in Norway. A national audit
A Wibe et al.
DISEASES OF THE COLON & RECTUM (2002)
Use of period analysis for providing more up-to-date estimates of long-term survival rates:: empirical evaluation among 370 000 cancer patients in Finland
H Brenner et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2002)
Up-to-date long-term survival curves of patients with cancer by period analysis
H Brenner et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
JS Macdonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Cancer survival increases in Europe, but international differences remain wide
M Sant et al.
EUROPEAN JOURNAL OF CANCER (2001)
High-dose therapy in lymphomas: A review of the current status of allogeneic and autologous stem cell transplantation in Hodgkin's disease and non-Hodgkin's lymphoma
SA Mink et al.
ONCOLOGIST (2001)
Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm
AL Martling et al.
LANCET (2000)
Are increasing 5-year survival rates evidence of success against cancer?
HG Welch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
